IRIS
PAGNESI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.893
AS - Asia 924
NA - Nord America 872
SA - Sud America 88
AF - Africa 20
OC - Oceania 2
Totale 3.799
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 1.293
US - Stati Uniti d'America 800
IT - Italia 290
SG - Singapore 283
CN - Cina 281
BD - Bangladesh 106
HK - Hong Kong 101
FR - Francia 89
BR - Brasile 60
SE - Svezia 50
GB - Regno Unito 47
VN - Vietnam 40
IN - India 39
DE - Germania 37
CA - Canada 32
MX - Messico 20
NL - Olanda 19
PL - Polonia 18
FI - Finlandia 15
JP - Giappone 14
ES - Italia 11
IQ - Iraq 10
TR - Turchia 9
AR - Argentina 7
AT - Austria 7
SA - Arabia Saudita 7
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
JM - Giamaica 6
CO - Colombia 5
EC - Ecuador 5
PH - Filippine 5
VE - Venezuela 5
CH - Svizzera 4
MY - Malesia 4
PK - Pakistan 4
HN - Honduras 3
KW - Kuwait 3
PT - Portogallo 3
SV - El Salvador 3
AZ - Azerbaigian 2
ID - Indonesia 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
MA - Marocco 2
NI - Nicaragua 2
PY - Paraguay 2
RO - Romania 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AI - Anguilla 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
AW - Aruba 1
BE - Belgio 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
GH - Ghana 1
HR - Croazia 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
PE - Perù 1
SN - Senegal 1
SO - Somalia 1
SR - Suriname 1
TW - Taiwan 1
UA - Ucraina 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
VU - Vanuatu 1
Totale 3.799
Salva come PNG Salva come JPEG
Città #
Moscow 262
Singapore 137
Ashburn 126
Hong Kong 99
San Jose 80
Milan 77
Lauterbourg 65
New York 63
Beijing 53
Council Bluffs 45
Orem 45
Los Angeles 29
Dallas 28
Shanghai 28
Santa Clara 25
Rome 22
Boardman 20
Chennai 20
Warsaw 15
Hefei 14
Ho Chi Minh City 14
Tokyo 14
Brescia 12
Lappeenranta 12
Munich 12
Manchester 11
Poplar 11
Denver 10
Naples 10
Brooklyn 9
Atlanta 8
Bologna 8
Hanoi 8
Lawrence 8
Mexico City 8
Princeton 8
São Paulo 8
Amsterdam 7
Frankfurt am Main 7
Nuremberg 7
Phoenix 7
Querétaro 7
Boston 6
Catania 6
Houston 6
Montreal 6
Turin 6
Buffalo 5
Cagliari 5
London 5
Monza 5
Mumbai 5
Stockholm 5
Toronto 5
Chicago 4
Da Nang 4
Ittigen 4
Newark 4
Reggio Emilia 4
Tianjin 4
Washington 4
Ankara 3
Baghdad 3
Caracas 3
Colliano 3
Delhi 3
Guanzate 3
Guayaquil 3
Johannesburg 3
Kingston 3
Kuwait City 3
Las Vegas 3
Miami 3
Padua 3
Palermo 3
Philadelphia 3
Rockville 3
San Salvador 3
Verona 3
Vienna 3
Vimodrone 3
Yalova 3
Amman 2
Betim 2
Bexley 2
Bismarck 2
Bucaramanga 2
Campinas 2
Curitiba 2
Dammam 2
Dhaka 2
Erbil 2
Falkenstein 2
Figino 2
Florence 2
Guangzhou 2
Haiphong 2
Helsinki 2
Jaipur 2
Jeddah 2
Totale 1.651
Salva come PNG Salva come JPEG
Nome #
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub 129
Impact of Left Ventricular Outflow Tract Calcification on Pacemaker Implantation After Transcatheter Aortic Valve Implantation With Second-Generation Devices 103
Device-related complications after Impella mechanical circulatory support implantation: An IMP-IT observational multicentre registry substudy 99
A novel scoring system and decisional algorithm to predict functional recovery after heart valve surgery 96
Integrated clinical role of echocardiography in patients with COVID-19 95
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19 93
Heart and Lung Multimodality Imaging in COVID-19 93
Neutrophil to lymphocyte ratio: a new preoperative predictive index of postoperative atrial fibrillation 89
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 79
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement 76
2024 update in heart failure 75
Predictors of high residual gradient after transcatheter aortic valve replacement in bicuspid aortic valve stenosis 75
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 72
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 67
Prevalence, Burden and Echocardiographic Features of Moderate to Severe Tricuspid Regurgitation: Insights from a Tertiary Referral Center (vol 3, pg 123, 2019) 61
Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management Strategies 50
Epidemiology, pathophysiology, diagnosis and management of atrial functional mitral regurgitation: An expert opinion paper 48
The Relevance of Right Ventricular Function and Dimension in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair 46
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 45
Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 45
Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial 44
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 43
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 41
Left Main Spontaneous Coronary Artery Dissection: Clinical Features, Management, and Outcomes 40
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial 40
Acute Heart Failure: Transitioning From Symptom-Based Care to Remission 39
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF Trial 39
Assessing aortic flow with doppler echocardiography in cardiogenic shock: A crucial diagnostic tool 39
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 38
Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial 37
Safety and Efficacy Intravenous Istaroxime up to 60 hours for Patients with Pre-Cardiogenic Shock 36
Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions 36
Malnutrition and outcomes in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve repair 36
Diuretic De-Escalation in Response to HF Therapy: Are We Closer to Reduced Reliance on Diuretics? 35
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 34
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF 34
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 34
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 33
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 33
Ventilation strategies in cardiogenic shock: Insights from the AltShock-2 registry 32
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis 32
Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review 32
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials 31
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 31
Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure 31
April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure 31
Characteristics, Prognosis and ESC/ERS Risk Stratification in Obese Patients with Pulmonary Arterial Hypertension (PAH) 30
Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF study 30
Obesity and inflammation in chronic and acute heart failure 30
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 29
Impact of SGLT2 inhibitors on endothelial function and echocardiographic parameters in dilated cardiomyopathy 29
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 29
Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry 29
Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry 29
Prognostic role of tricuspid annular plane systolic excursion/pulmonary artery systolic pressure ratio in patients hospitalized for acute heart failure 28
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: a sub-analysis of the STRONG-HF randomized clinical trial 28
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 28
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC 27
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 27
Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 27
Noncardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: insights from the STRONG-HF trial 27
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 26
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 26
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial 26
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure 26
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 25
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF 25
Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction 25
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 24
Towards a phenotype profiling of the patients with heart failure and preserved ejection fraction 24
Intra-Aortic Balloon Pumping in Acute Decompensated Heart Failure With Hypoperfusion: From Pathophysiology to Clinical Practice 24
Combined pre- and post-capillary pulmonary hypertension in left heart disease 24
Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists 24
Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE 24
Clinical Impact of Renal Dysfunction in Patients with Severe Tricuspid Regurgitation and Chronic Heart Failure 24
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrum 23
Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation 23
NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial 23
Prognostic role of mitral regurgitation in patients with advanced heart failure 23
Heart failure: an update from the last years and a look at the near future 23
Reply to the letter regarding the article ‘Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure’ 23
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 23
Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients with Pre Cardiogenic Shock 22
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial 22
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 22
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial 22
Corticosteroid burst therapy in patients with acute heart failure: Design of the CORTAHF pilot study 21
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF 21
Pre-admission beta-blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock-2 Registry 21
Functional Mitral Regurgitation and Heart Failure With Preserved Ejection Fraction: Clinical Implications and Management 21
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 21
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 20
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trial 20
February 2021 at a glance: focus on amyloidosis, myocarditis and cardiomyopathy 20
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial 20
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 20
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study 20
Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment 20
Ejection fraction in heart failure: just become Emperor's new clothes? 19
Mapping of current practices of palliative care for patients with heart failure throughout Europe: A scoping review 19
Totale 3.773
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.324
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212 0 0 0 7 3 1 0 1 0 0 0 0
2022/202362 19 15 5 0 0 9 0 8 0 0 2 4
2023/202473 0 5 12 10 12 6 2 15 0 0 6 5
2024/2025230 13 11 2 6 10 31 52 31 15 17 16 26
2025/20263.735 85 45 17 113 169 480 382 334 1.385 353 206 166
Totale 4.139